Massachusetts Financial Services Co. MA Has $105.10 Million Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Massachusetts Financial Services Co. MA raised its holdings in Teleflex Incorporated (NYSE:TFX) by 38.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 590,529 shares of the medical technology company’s stock after buying an additional 162,950 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Teleflex were worth $105,102,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the business. HighTower Advisors LLC increased its position in Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after acquiring an additional 66 shares during the period. Hengehold Capital Management LLC increased its holdings in shares of Teleflex by 7.3% during the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after purchasing an additional 88 shares during the period. Exchange Traded Concepts LLC raised its position in shares of Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after buying an additional 94 shares during the last quarter. Isthmus Partners LLC lifted its stake in shares of Teleflex by 7.3% in the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock valued at $273,000 after buying an additional 105 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its position in Teleflex by 2.4% during the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company’s stock worth $888,000 after buying an additional 118 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Wells Fargo & Company cut their price target on Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Truist Financial reduced their target price on Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research report on Monday, March 3rd. Royal Bank of Canada lowered shares of Teleflex from an “outperform” rating to a “sector perform” rating and lowered their price target for the company from $220.00 to $155.00 in a report on Friday, February 28th. Raymond James downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Finally, StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Teleflex has an average rating of “Hold” and a consensus price target of $182.63.

Teleflex Stock Performance

NYSE:TFX opened at $131.93 on Friday. The stock has a market capitalization of $6.12 billion, a P/E ratio of 26.23, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.91. The firm has a 50 day moving average of $154.86 and a 200-day moving average of $187.03.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. As a group, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date was Friday, March 7th. Teleflex’s dividend payout ratio is currently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.